Literature DB >> 33537880

When and how should peritoneal endometriosis be operated on in order to improve fertility rates and symptoms? The experience and outcomes of nearly 100 cases.

A M Dückelmann1, E Taube2, E Abesadze3, V Chiantera4, J Sehouli1, S Mechsner5.   

Abstract

PURPOSE: To analyze the follow-up results of patients suffering from symptomatic early-stage endometriosis after a consistent laparoscopic peritoneal stripping of the altered peritoneum (peritoneal endometriosis and surrounding inflamed tissue) was performed. This type of endometriosis is resistant to medical therapy and/or impairs fertility.
METHODS: Using our prospectively maintained database, we were able to identify all symptomatic women with the suspicion of only peritoneal endometriosis who underwent laparoscopy at our endometriosis center over a period of 5 years. All procedures were carried out in a standardized fashion by one single surgeon, who is highly experienced in minimal invasive surgery, and included a suspended hormonal pretreatment for 2 months. Postoperative outcomes including complications, fertility and recurrence rates were analysed.
RESULTS: Laparoscopic peritonectomy was performed on 94 women. Follow-up data were available in 87% of these cases. At the time of surgery, almost all patients tested showed signs of stage I or II endometriosis (44.7 and 48.9%, respectively). More than three-quarters of the women reported pain relief, inter alia, due to the post-surgical hormonal therapy. About one-third of the patients wanted to have children after the procedure. 62% of them became pregnant and the majority did so without the need for assisted reproductive therapy. In seven women a re-operation was performed.
CONCLUSION: According to our data, a consistent excision of altered peritoneum followed by adjuvant hormonal therapy and multimodal concepts results in better outcomes for the patient, particularly in regards to pregnancy and recurrence rates.

Entities:  

Keywords:  Infertility; Laparoscopic surgery; Pelvic pain; Peritoneal endometriosis; Peritonectomy

Year:  2021        PMID: 33537880     DOI: 10.1007/s00404-021-05971-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  63 in total

1.  Proteomic analysis of peritoneal fluid in women with endometriosis.

Authors:  Simone Ferrero; David J Gillott; Valentino Remorgida; Paola Anserini; Kit-Yi Leung; Nicola Ragni; Jurgis G Grudzinskas
Journal:  J Proteome Res       Date:  2007-08-03       Impact factor: 4.466

2.  Characterization of endometriosis-associated immune cell infiltrates (EMaICI).

Authors:  Claudia Scheerer; Petia Bauer; Vito Chiantera; Jalid Sehouli; Andreas Kaufmann; Sylvia Mechsner
Journal:  Arch Gynecol Obstet       Date:  2016-06-29       Impact factor: 2.344

Review 3.  Endometriosis: where are we and where are we going?

Authors:  Alexis D Greene; Stephanie A Lang; Jessica A Kendziorski; Julie M Sroga-Rios; Thomas J Herzog; Katherine A Burns
Journal:  Reproduction       Date:  2016-05-10       Impact factor: 3.906

Review 4.  Endometriosis.

Authors:  Krina T Zondervan; Christian M Becker; Kaori Koga; Stacey A Missmer; Robert N Taylor; Paola Viganò
Journal:  Nat Rev Dis Primers       Date:  2018-07-19       Impact factor: 52.329

5.  Neuroimmunomodulatory alterations in non-lesional peritoneum close to peritoneal endometriosis.

Authors:  Julia Arnold; Giuseppe Filiberto Vercellino; Vito Chiantera; Achim Schneider; Sylvia Mechsner; Maria Luisa Barcena de Arellano
Journal:  Neuroimmunomodulation       Date:  2012-11-14       Impact factor: 2.492

6.  Effect of menstruation and intrapelvic injection of endometrium on inflammatory parameters of peritoneal fluid in the baboon (Papio anubis and Papio cynocephalus).

Authors:  T M D'Hooghe; C S Bambra; L Xiao; K Peixe; J A Hill
Journal:  Am J Obstet Gynecol       Date:  2001-04       Impact factor: 8.661

7.  Abdominal Wall Endometriosis: Myofibroblasts as a Possible Evidence of Metaplasia: A Case Report.

Authors:  Mohamed Gamal Ibrahim; Eleonore Delarue; Elene Abesadze; Matthias Haas; Jalid Sehouli; Vito Chiantera; Sylvia Mechsner
Journal:  Gynecol Obstet Invest       Date:  2016-11-04       Impact factor: 2.031

8.  Macrophages and nerve fibres in peritoneal endometriosis.

Authors:  Lu Vinh Phuc Tran; Natsuko Tokushige; Marina Berbic; Robert Markham; Ian S Fraser
Journal:  Hum Reprod       Date:  2009-01-09       Impact factor: 6.918

9.  Endometriosis results from the dislocation of basal endometrium.

Authors:  G Leyendecker; M Herbertz; G Kunz; G Mall
Journal:  Hum Reprod       Date:  2002-10       Impact factor: 6.918

10.  The Expression and Cellular Localisation of Neurotrophin and Neural Guidance Molecules in Peritoneal Ectopic Lesions.

Authors:  Razan Asally; Robert Markham; Frank Manconi
Journal:  Mol Neurobiol       Date:  2018-09-25       Impact factor: 5.590

View more
  4 in total

1.  Effectiveness of gonadotrophin-releasing hormone agonist therapy to improve the outcomes of intrauterine insemination in patients suffering from stage I-II endometriosis.

Authors:  Kemei Zhang; Shisi Huang; Haiyan Xu; Jiaou Zhang; Ensheng Wang; Yang Li; Changling Zhu; Jing Shu
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 2.  Neurogenic Inflammation in the Context of Endometriosis-What Do We Know?

Authors:  Renata Voltolini Velho; Eliane Taube; Jalid Sehouli; Sylvia Mechsner
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

3.  Determinants of Pain-Induced Disability in German Women with Endometriosis during the COVID-19 Pandemic.

Authors:  Roxana Schwab; Kathrin Stewen; Tanja Kottmann; Susanne Theis; Tania Elger; Bashar Haj Hamoud; Mona W Schmidt; Katharina Anic; Walburgis Brenner; Annette Hasenburg
Journal:  Int J Environ Res Public Health       Date:  2022-07-06       Impact factor: 4.614

4.  Factors Associated with Increased Analgesic Use in German Women with Endometriosis during the COVID-19 Pandemic.

Authors:  Roxana Schwab; Kathrin Stewen; Tanja Kottmann; Mona W Schmidt; Katharina Anic; Susanne Theis; Bashar Haj Hamoud; Tania Elger; Walburgis Brenner; Annette Hasenburg
Journal:  J Clin Med       Date:  2022-09-21       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.